Among these, exon 20 insertion mutations, accounting for 4–12% of cases of EGFR-mutated NSCLC, are the most frequent and are described especially in the Asian population and in non-smoker patients and are characterized by a poor response (less than 10%) to TKIs [6]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.